Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

172060 Andrographolide - CAS 5508-58-7 - Calbiochem

A bicyclic diterpenoid lactone that displays anti-viral, anti-inflammatory, anti-apoptotic, and anti-hyperglycemic properties.

Andrographolide - CAS 5508-58-7 - Calbiochem MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

同义词: Andro

Primary Target: NF-κB and AP-1 activation
172060
Purchase on Sigma-Aldrich

概述

Replacement Information

重要规格表

CAS #Empirical Formula
5508-58-7C₂₀H₃₀O₅

Products

产品目录编号包装 数量 / 包装
172060-50MGCN 塑胶安瓿;塑胶针药瓶 50 mg
Description
OverviewA bicyclic diterpenoid lactone that displays anti-viral, anti-inflammatory, anti-apoptotic, and anti-hyperglycemic properties. Acts as an irreversible antagonist of NF-κB and AP-1 (IC50 ≤ 15 µM) activation, and prevents in vitro and in vivo T cell activation. Exerts no effect on IκBα degradation, p50 and p65 nuclear translocation. Inhibits iNOS and Mac-1 expressions and ROS production, and prevents endotoxin shock in mouse model. Further, reported to activate PI 3K/Akt pathway.
Catalogue Number172060
Brand Family Calbiochem®
SynonymsAndro
References
ReferencesXia, Y.F., et al. 2004. J. Immunol. 173, 4207.
Chen, J.H., et al. 2004. Biochem. Pharmacol. 67, 1337.
Yu, B.C., et al. 2003. Planta Med. 69, 1075.
Product Information
CAS number5508-58-7
ATP CompetitiveN
FormOff-white solid
Hill FormulaC₂₀H₃₀O₅
Chemical formulaC₂₀H₃₀O₅
ReversibleN
Structure formula ImageStructure formula Image
Quality LevelMQ100
Applications
Biological Information
Primary TargetNF-κB and AP-1 activation
Primary Target IC<sub>50</sub>≤ 15 µM against NF-κB and AP-1 activation
Purity≥95% by TLC
Physicochemical Information
Cell permeableN
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
RTECSLU3490750
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Ambient Temperature Only
Toxicity Carcinogenic / Teratogenic
Storage +2°C to +8°C
Protect from Light Protect from light
Do not freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Packaging Information
Packaged under inert gas Packaged under inert gas
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
产品目录编号 GTIN
172060-50MGCN 04055977222883

Documentation

Andrographolide - CAS 5508-58-7 - Calbiochem MSDS

职位

物料安全数据表 (MSDS) 

Andrographolide - CAS 5508-58-7 - Calbiochem 分析证书

标题批号
172060

参考

参考信息概述
Xia, Y.F., et al. 2004. J. Immunol. 173, 4207.
Chen, J.H., et al. 2004. Biochem. Pharmacol. 67, 1337.
Yu, B.C., et al. 2003. Planta Med. 69, 1075.
数据表

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision14-April-2008 RFH
SynonymsAndro
DescriptionAn irreversible blocker of NF-κB and AP-1 (IC50 ≤ 15 µM) activation that displays anti-viral, anti-inflammatory, anti-apoptotic, and anti-hyperglycemic properties. Exerts no effect on IκBα degradation of nuclear translocation p50 and p65. Inhibits iNOS and Mac-1 expressions and ROS production, and prevents endotoxin shock in a mouse model. Reported to supress Cytochrome C release and apoptosis by activating the PI 3-K/Akt pathway.
FormOff-white solid
Intert gas (Yes/No) Packaged under inert gas
CAS number5508-58-7
RTECSLU3490750
Chemical formulaC₂₀H₃₀O₅
Structure formulaStructure formula
Purity≥95% by TLC
SolubilityDMSO (15 mg/ml) or Chloroform:Methanol (1:1) (10 mg/ml). Use only fresh DMSO.
Storage Protect from light
+2°C to +8°C
Do Not Freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Toxicity Carcinogenic / Teratogenic
Merck USA index14, 633
ReferencesXia, Y.F., et al. 2004. J. Immunol. 173, 4207.
Chen, J.H., et al. 2004. Biochem. Pharmacol. 67, 1337.
Yu, B.C., et al. 2003. Planta Med. 69, 1075.